Hydrochloric Acid → 5-Methyl-2-(3-(piperidin-4-ylidenemethyl)phenoxy)pyridine hydrochloride
Reaktionsgleichung
[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([O:8][C:9]2[CH:10]=[C:11]([CH:26]=[CH:27][CH:28]=2)[CH:12]=[C:13]2[CH2:18][CH2:17][N:16](C(OC(C)(C)C)=O)[CH2:15][CH2:14]2)=[N:6][CH:7]=1.[ClH:29].O1CCOCC1>C(Cl)Cl>[ClH:29].[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([O:8][C:9]2[CH:28]=[CH:27][CH:26]=[C:11]([CH:12]=[C:13]3[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]3)[CH:10]=2)=[N:6][CH:7]=1Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
tert-Butyl 4-(3-(5-methylpyridin-2-yloxy)benzylidene)piperidine-1-carboxylate (1.24 g, 3.26 mmol) from Step 4 was dissolved in CH2Cl2 (10 mL) and treated with HCl in dioxane (3.26 mL, 4.0 M, 13 mmol). After 16 h the reaction was concentrated in vacuo to provide the title compound as a white solid (1.48 g).
Aufarbeitung
- concentrationAfter 16 h the reaction was concentrated in vacuo
Quellen und Nachweise
- ORD-Eintrag
- ord-55f77b2d122f427c95b1a64a0b1ab813
- Quelldatensatz
- uspto-grants-2011_10
- Patentnummer
- US08044052B2
Notizen zur Reaktion
Wird geladen…